Europe Nuclear Imaging Industry is at the cusp of crossing $3.81 billion in 2021

According to the report Europe Nuclear Imaging Industry, published by Market Data Forecast, The Industry was worth $2.50 billion in 2016 and estimated to be growing at a CAGR of 8.78%, to reach $3.81 billion by 2021.

Medical imaging is the method of generating a photographic image of the inside of the body for medical intervention. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately. Nuclear imaging is most commonly utilized for cardiovascular and oncology applications. It refers to the method of generating visuals of the organs of the body by processing minor quantity of radioactive tracers. The images are obtained using a gamma camera and can be documented on film or on a computer.

Browse Market data tables and in-depth TOC of the Europe Nuclear Imaging Industry to 2021 @ http://www.marketdataforecast.com/market-reports/europe-nuclear-imaging-market-1625/

The growth of the Europe Nuclear Imaging Industry is mainly due to factors such as an increase in the number of cancer and cardiovascular disease cases, and predilection towards minimally invasive procedures, ready availability of radiopharmaceuticals. However, factors such as costly procedures & equipment, shortage of supplies, and logistical difficulties are hampering the growth of the Industry in this region.

The Europe Nuclear Imaging Industry is segmented based on Diagnostic Technologies and Application. The Industry for Nuclear Imaging, on the basis of Diagnostic Technologies is segmented into PET Radioisotopes and SPECT Radioisotopes. PET Radioisotopes are further segmented into Rubidium-82, Fluorine-18, whereas SPECT Radioisotopes are further segmented into Thallium-201, Technetium-99m, Xenon-133, and Iodine-123. On the basis of Application, the Nuclear Imaging Industry is segmented into PET and SPECT. PET is further segmented into Cardiology, Oncology, and Neurology, whereas SPECT is segmented into Lymphoma, Neurology, Cardiology, and Thyroid. PET is mainly being utilized in oncology due to superior quality of imaging; Whereas SPECT is used in the cardiology section accounting for almost 80% of the entire cardiology Industry share.

Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-nuclear-imaging-market-1625/request-sample

The Europe Industry has been geographically segmented into Germany, U.K, France, Spain, and Italy. In 2015, Germany accounted for the largest share of the Nuclear Imaging Industry, followed by France, Italy, and U.K. This Industry is however projected to witness high growth rate in nascent Industrys such as Switzerland, Poland, Denmark, and Sweden. Companies are showing a strong interest in enhancing image quality by developing new technologies and creating new devices or novel techniques to achieve images with higher spatial resolution.

The major companies dominating the Nuclear Imaging Industry in this region are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.

Inquire before buying @ http://www.marketdataforecast.com/market-reports/europe-nuclear-imaging-market-1625/inquire

Key Points from Table of Contents
Overview
• Executive Summary
• Key Inferences
• New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Europe Nuclear Imaging Industry: Segmentation
• Diagnostic Technologies
o PET Radioisotopes
o SPECT Radioisotopes
• Application
o PET
o SPECT
Geographical Analysis
• U.K
• Spain
• Germany
• Italy
• France
Strategic Analysis
• PESTLE analysis
• Porter’s Five analysis
Industry Leaders' Analysis
Competitive Landscape

Avail discount @ http://www.marketdataforecast.com/market-reports/europe-nuclear-imaging-market-1625/request-discount

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.

This release was published on openPR.